Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

Seeking Alpha / 13 hours ago 3 Views

Regulatory filing marks significant milestone for medication designed to provide once-daily, entire active-day symptom control in ADHD patients 
Regulatory filing marks significant milestone for medication designed to provide once-daily, entire active-day symptom control in ADHD patients
Read more

Comments